XML 52 R29.htm IDEA: XBRL DOCUMENT v3.21.1

SEGMENT INFORMATION (Tables)

3 Months Ended

Mar. 31, 2021

Segment Reporting [Abstract]

Information About Reportable Segments and Reconciliation of Segment Net Sales to Consolidated Net Sales and Segment Pre-Tax Income to Consolidated Pre-Tax Income

The table below presents information about Edwards Lifesciences' reportable segments (in millions):

									Three Months Ended March 31,
															2021						2020
Segment Net Sales
United States															$	674.7					$	667.4
Europe															255.4						247.5
Japan															127.7						109.8
Rest of World															124.5						104.4
Total segment net sales															$	1,182.3					$	1,129.1
Segment Operating Income
United States															$	466.1					$	464.8
Europe															133.3						128.0
Japan															87.6						71.7
Rest of World															47.3						34.9
Total segment operating income															$	734.3					$	699.4

The table below presents reconciliations of segment net sales to consolidated net sales and segment operating income to consolidated pre-tax income (in millions):

									Three Months Ended March 31,
															2021						2020
Net Sales Reconciliation
Segment net sales															$	1,182.3					$	1,129.1
Foreign currency															34.3						(0.4)
Consolidated net sales															$	1,216.6					$	1,128.7
Pre-tax Income Reconciliation
Segment operating income															$	734.3					$	699.4
Unallocated amounts:
Corporate items															(357.7)						(340.7)
Intellectual property litigation expenses															(6.4)						(12.5)
Change in fair value of contingent consideration liabilities															4.5						2.2
Foreign currency															8.8						9.7
Consolidated operating income															383.5						358.1
Non-operating income															5.8						6.4
Consolidated pre-tax income															$	389.3					$	364.5

Enterprise-Wide Information

The following enterprise-wide information is based on actual foreign exchange rates used in the Company's consolidated condensed financial statements.

									Three Months Ended March 31,
															2021						2020
															(in millions)
Net Sales by Geographic Area
United States															$	674.7					$	667.4
Europe															280.0						249.3
Japan															132.3						110.0
Rest of World															129.6						102.0
															$	1,216.6					$	1,128.7
Net Sales by Major Product Area
Transcatheter Aortic Valve Replacement															$	791.7					$	742.2
Transcatheter Mitral and Tricuspid Therapies															16.3						10.5
Surgical Structural Heart															213.0						193.4
Critical Care															195.6						182.6
															$	1,216.6					$	1,128.7

			March 31, 2021						December 31, 2020
			(in millions)
Long-lived Tangible Assets by Geographic Area
United States			$	1,101.0					$	1,084.3
Europe			201.4						192.7
Japan			18.0						20.4
Rest of World			310.3						311.0
			$	1,630.7					$	1,608.4

X

- Definition

Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1)
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227

+ Details

Name:	us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration